Clinical validation of high risk HPV DNA testing versus ThinPrep cytology for primary cervical cancer screening

Clinical validation of high risk HPV DNA testing versus ThinPrep cytology for primary cervical cancer screening

Objective(s): To compare the validity of the high risk HPV DNA testing using the hybrid capture II technique (HC-II) to ThinPrep cytology for primary cervical cancer screening. Design: Cross sectional pilot study. Setting: Department of Obstetrics and Gynecology, Taiba Hospital, Sabah Al Salem, Kuwa...

Full description

Bibliographic Details
Main Authors: Mahmoud El-Morsi Aboul-Fotouh, Ihab Talaat Hana
Format: Article
Language:English
Published: SpringerOpen 2013-06-01
Series:Middle East Fertility Society Journal
Subjects:
HPV
HPV DNA testing
Pap smear
ThinPrep cytology
Cervical cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S1110569012001227

Internet

http://www.sciencedirect.com/science/article/pii/S1110569012001227

Similar Items